Work Here?
Overview
Senseye creates a Software as a Medical Device for mental health diagnosis, starting with PTSD. It uses a smartphone app to record eye responses with the front camera while users perform simple visual tasks, extracting digital biomarkers from pupil gaze and iris biomechanics. A proprietary machine learning algorithm analyzes these signals to produce a diagnostic report with a severity score within minutes, without specialized hardware. Its goal is to replace subjective self-reports and expand to a broader panel of mental health disorders (like MDD and GAD) for baseline assessment and monitoring of treatment outcomes.
About Senseye
Industries
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$8M
Headquarters
Bellflower, California
Founded
2015
Get referred to Senseye
See people who can refer or advise you
Simplify's Take
What believers are saying
- Senseye published 2026 peer-reviewed PTSD findings and two ADAA feasibility posters.
- Topcon announced on 2025-09-09 a strategic investment, signaling commercial validation.
- Senseye says it is progressing toward FDA-regulated medical use as of 2026-07-28.
What critics are saying
- Senseye still lacks FDA authorization, leaving sales dependent on research use and pilots.
- The 2026 veteran study enrolled only 38 patients, exposing fragile evidence for scale.
- If FDA rejects Senseye's SaMD, the company loses its diagnostic business model.
What makes Senseye unique
- Senseye's smartphone eye-biomarker platform measures PTSD without trauma disclosure, unlike questionnaires.
- Its 2026 study showed iPhone pupillometry tracked PTSD severity in 38 veterans.
- Topcon's 2025 strategic investment connects Senseye to ocular-data distribution and Harmony integration.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$8M
Below
Industry Average
Funded Over
4 Rounds
Industry standards
Benefits
Stock Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Flexible Work Hours
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Life Insurance
Commuter Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -2%Topcon Healthcare, Inc. makes strategic investment in Senseye, Inc. to advance mental health diagnostics through ocular biomarkers.
Topcon Healthcare has invested in Senseye, which is developing a mental health diagnostic platform using ocular biomarkers. Senseye's technology employs AI to analyze eye movements via smartphone cameras, aiding in diagnosing PTSD, MDD, and GAD. This investment marks Topcon's first foray into mental health, aiming to integrate Senseye's tech into its Harmony platform for a comprehensive view of patients' health. Financial terms were not disclosed.
Topcon Healthcare announced a strategic investment in Senseye, which is developing a mental health diagnostic platform powered by ocular biomarke
For Zakariaie, whose company Senseye is developing AI tools for behavioral health, the key is intentional dataset design.
Kinled is renowned as a life sciences and financial technology investor, with a portfolio of over 125 investments. Within their portfolio are nearly 50 companies specialised in cutting edge digital technology. The advent of AI has altered the investment strategy of Patrick Aisher, Chairman of Hong Kong-based Kinled Holding Limited, who has established a global investment network. “Approximately 25% of our technology portfolio is directly involved in Artificial Intelligence applications”, says Aisher. “In reality, the use of massive computational power in life sciences and molecular drug discovery has been standard for many years, and this type of approach is now being applied to other industries. Kinled was an early investor in the first-ever FDA-approved AI diagnostic platform, and now has AI and machine-learning investments across multiple industries.”
Senseye is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Senseye
Industries
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$8M
Headquarters
Bellflower, California
Founded
2015
Senseye is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today